Skip to content

Laith Alexander

6 papers in the library · 154 citations · publishing 2020-2026

Papers

Sort Most recent Most cited

Structural imaging predictors of ketamine response in treatment-resistant depression: a machine learning approach.

Translational Psychiatry May 12, 2026 Linda Bryant, Laith Alexander, Sergio Mena et al.

Ketamine has demonstrated rapid antidepressant efficacy in treatment-resistant depression (TRD), but clinical decision-making is challenging due to variability in individual response. Current trial-and-error prescribing practices may expose patients to ineffective treatment and avoidable adverse effects, underscoring the need for reliable predictive tools to optimize treatment selection and...

Preclinical models for evaluating psychedelics in the treatment of major depressive disorder.

British Journal of Pharmacology October 28, 2024 Laith Alexander, Dasha Anderson, Luke Baxter et al. 11 citations

Psychedelic drugs have seen a resurgence in interest as a next generation of psychiatric medicines with potential as rapid-acting antidepressants (RAADs). Despite promising early clinical trials, the mechanisms which underlie the effects of psychedelics are poorly understood. For example, key questions such as whether antidepressant and psychedelic effects involve related or independent...

Preliminary evidence that ketamine alters anterior cingulate resting-state functional connectivity in depressed individuals

Translational Psychiatry December 3, 2023 Laith Alexander, Peter C. T. Hawkins, Jennifer W. Evans et al. 26 citations

Abstract Activity changes within the anterior cingulate cortex (ACC) are implicated in the antidepressant effects of ketamine, but the ACC is cytoarchitectonically and functionally heterogeneous and ketamine’s effects may be subregion specific. In the context of a double-blind randomized placebo-controlled crossover trial investigating the clinical and resting-state fMRI effects of intravenous...

A transdiagnostic systematic review and meta-analysis of ketamine’s anxiolytic effects

medRxiv December 11, 2022 Hannah Hartland, Kimia Mahdavi, Luke A. Jelen et al. 22 citations

Background: Ketamine may be effective in treating symptoms of anxiety, but the time profile of ketamine’s anxiolytic effect is ill-defined. This systematic review and meta-analysis investigated the anxiolytic effect of ketamine at different time points across a range of clinical settings. Methods: Electronic databases were searched to capture randomised control trials measuring the anxiolytic...

The anterior cingulate cortex as a key locus of ketamine’s antidepressant action

Neuroscience & Biobehavioral Reviews May 10, 2021 Laith Alexander, Luke A. Jelen, Mitul A. Mehta et al. 79 citations

The subdivisions of the anterior cingulate cortex (ACC) - including subgenual, perigenual and dorsal zones - are implicated in the etiology, pathogenesis and treatment of major depression. We review an emerging body of evidence which suggests that changes in ACC activity are critically important in mediating the antidepressant effects of ketamine, the prototypical member of an emerging class of...

Psychedelic science in post-COVID-19 psychiatry

Irish Journal of Psychological Medicine August 19, 2020 John R. Kelly, Matthew Crockett, Laith Alexander et al. 16 citations

The medium- to long-term consequences of COVID-19 are not yet known, though an increase in mental health problems are predicted. Multidisciplinary strategies across socio-economic and psychological levels may be needed to mitigate the mental health burden of COVID-19. Preliminary evidence from the rapidly progressing field of psychedelic science shows that psilocybin therapy offers a promising...